Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12610000639022
Ethics application status
Approved
Date submitted
4/08/2010
Date registered
5/08/2010
Date last updated
5/08/2010
Type of registration
Prospectively registered
Titles & IDs
Public title
Contralateral, cross over clinical trial to assess the effect of novel and commercially available contact lenses on corneal topography
Query!
Scientific title
A prospective, open-label, contralateral daily wear, cross over, randomised clinical trial assessing the effect of wearing a novel and five commercially available contact lenses for 1 week on corneal topography worn in experienced myopic contact lens wearers
Query!
Secondary ID [1]
252195
0
nil
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Corneal Topography
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Contact Lens Wear
Corneal Topography
257728
0
Query!
Condition category
Condition code
Eye
257902
257902
0
0
Query!
Normal eye development and function
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
5 Commercially available contact lenses (AIR OPTIX [Trade mark] Aqua, AIR OPTIX [Trade mark] Aqua Multifocal, NIGHT & DAY [Registered trade mark], ACUVUE 2 [Trade mark], Avaira [Trade mark])and 1 novel optical design silicone hydrogel contact lens have been chosen as test products to examine the effect of modulus and lens design on corneal topography after 1 week of wear. The novel optical design is manufactured from the same material as AIR OPTIX [trademark] Aqua and has a different optical power distribution in the lens periphery. Contact lenses are suitable to be worn for 2 weeks, however, the 6 types of contact lenses will each be worn on a daily basis for approximately 1 week. Contact lens designs will be dispensed contralaterally by randomisation. Between each change of contact lens design contact lenses may not be worn for 1 calendar day, "1 day washout period", prior to each dispensing visit.
Query!
Intervention code [1]
256790
0
Treatment: Devices
Query!
Comparator / control treatment
The control will be the corneal topographical map captured prior to each lens dispense after 1 calendar day of no contact lens wear.
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
258765
0
To determine the effect of contact lenses on corneal topography in a myopic population after 8 hours and 1 week of contact lens (CL) wear.
Query!
Assessment method [1]
258765
0
Query!
Timepoint [1]
258765
0
Baseline, 1 week, 2 weeks, 3 weeks of contact lens wear
Query!
Secondary outcome [1]
264824
0
1) To determine the effect on peripheral refraction profiles during contact lens wear with the use of a modified Shin Nippon N-Vision K5001 Autorefractor.
2) To determine axial length after 1 week of CL wear in a small myopic population as determined by an IOL Master optical biometer.
Query!
Assessment method [1]
264824
0
Query!
Timepoint [1]
264824
0
Baseline, 1 week, 2 weeks, 3 weeks of contact lens wear
Query!
Eligibility
Key inclusion criteria
- be able to read and comprehend English and give informed consent as demonstrated by signing a record of informed consent. If participant is a child or adolescent, a parent or legal guardian must be able to provide this consent,
- be between the ages of 18 and 45 years old inclusive
- be myopic (short sighted) -0.75D to -4.25D with astigmatism no more than -1.00 D
- be willing to comply with the wearing and clinical trial visit schedule as directed by the investigator;
- have ocular health findings considered to be “normal” and which would not prevent the participant from safely wearing contact lenses;
- have vision correctable to at least 6/12 (20/40) or better in each eye with contact lenses.
- be experienced wearing contact lenses
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
45
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
Yes
Query!
Key exclusion criteria
- Pre-existing ocular irritation that would preclude contact lens fitting;
- Strabismus or amblyopia;
- Any ocular condition that may preclude safe wearing of contact lenses (e.g. active corneal infection, severe dry eye, reduced corneal sensitivity, exophthalmos/lagophthalmos, facial nerve palsy);
- Active corneal infection (bacterial, viral, fungal or protozoan) or any active ocular disease such as iritis, corneal oedema or corneal dystrophies, including anterior membrane dystrophy that would affect wearing of contact lenses;
- Any systemic disease that may adversely affect ocular health e.g. diabetes, Graves disease, and auto-immune diseases such as ankolysing spondylitis, multiple sclerosis, Sjögrens syndrome and systemic lupus erythematosis. Conditions such as systemic hypertension and arthritis do not automatically exclude prospective participants;
- Eye surgery within 12 weeks immediately prior to enrolment for this trial;
- Previous corneal refractive surgery;
- Any ocular injury or condition (including keratoconus and herpes keratitis) of the cornea, conjunctiva or eyelids that would affect the wearing of contact lenses;
- Contraindications to hydrogel contact lens wear;
- Worn orthokeratology lenses within the past 3 months;
- Currently enrolled in another clinical trial;
- Pregnancy (verbal report from participant will suffice).
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Crossover
Query!
Other design features
Query!
Phase
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Not yet recruiting
Query!
Date of first participant enrolment
Anticipated
6/08/2010
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
28
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
Query!
Funding & Sponsors
Funding source category [1]
257275
0
Charities/Societies/Foundations
Query!
Name [1]
257275
0
Brien Holden Vision Institute
Query!
Address [1]
257275
0
Level 5 North Wing
Rupert Myers Building
Gate 14 Barker St,
University of New South Wales (UNSW) Sydney NSW 2052
Query!
Country [1]
257275
0
Australia
Query!
Primary sponsor type
Other Collaborative groups
Query!
Name
CIBA VISION Corporation
Query!
Address
Continuous Wear Category R&D
11460 John Creek Parkway
Duluth, Atlanta GA 30097-1556, USA
Query!
Country
United States of America
Query!
Secondary sponsor category [1]
256518
0
None
Query!
Name [1]
256518
0
Query!
Address [1]
256518
0
Query!
Country [1]
256518
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
259301
0
VIHEC Human Research Ethics Committee
Query!
Ethics committee address [1]
259301
0
Level 4, North Wing, Rupert Myers Building (RMB) Gate 14, Barker Street The University of New South Wales SYDNEY, NSW 2052, AUSTRALIA
Query!
Ethics committee country [1]
259301
0
Australia
Query!
Date submitted for ethics approval [1]
259301
0
17/06/2010
Query!
Approval date [1]
259301
0
04/08/2010
Query!
Ethics approval number [1]
259301
0
1/07/2010
Query!
Summary
Brief summary
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
31383
0
Query!
Address
31383
0
Query!
Country
31383
0
Query!
Phone
31383
0
Query!
Fax
31383
0
Query!
Email
31383
0
Query!
Contact person for public queries
Name
14630
0
Judy Kwan
Query!
Address
14630
0
Level 5 North Wing
Rupert Myers Building
Gate 14 Barker St
UNSW Sydney NSW 2052
Query!
Country
14630
0
Australia
Query!
Phone
14630
0
+61 2 9385 7516
Query!
Fax
14630
0
Query!
Email
14630
0
[email protected]
Query!
Contact person for scientific queries
Name
5558
0
Judy Kwan
Query!
Address
5558
0
Level 5 North Wing
Rupert Myers Building
Gate 14 Barker St
UNSW Sydney NSW 2052
Query!
Country
5558
0
Australia
Query!
Phone
5558
0
+61 2 9385 7516
Query!
Fax
5558
0
Query!
Email
5558
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF